Oura Targets $16 Billion Valuation in Nasdaq IPO Filing
Oura, the Finnish company known for its smart rings that monitor sleep, has officially filed its S-1 registration statement with the SEC, targeting a Nasdaq listing under the ticker OURA. This move could potentially value the company at $16 billion, prompting investors to reconsider how they assess hardware companies that also rely on subscription revenue.
For the nine months ending June 30, 2026, Oura reported $1.21 billion in revenue, marking a 74% increase from $697.6 million during the same period the previous year. The company achieved a net income of $60.8 million, although the overall financial picture is complicated by significant losses.
For Your Trading Desk
Sponsor Spike Success.
Oura's revenue is divided into two main categories: hardware sales and subscription services. Sales of the smart rings contributed $974 million, while membership subscriptions added $240 million to the total revenue. The subscription service boasts an impressive 89% gross margin, and Oura currently has around 5 million paid members, maintaining an 85% retention rate over the past year. As of June 30, 2026, the company had shipped 3.1 million rings.
However, the S-1 filing also reveals a broader loss of $924.3 million for the nine-month period, primarily due to a $1.09 billion deemed dividend linked to early investor cash-outs. This figure raises questions about the sustainability of Oura's financial model despite its apparent revenue success.
Oura's Recent Funding and Projected Valuation Surge
In its last private funding round in October 2025, Oura raised between $875 million and $900 million, which valued the company at approximately $11 billion. Analysts at Bloomberg suggest that the upcoming IPO could elevate Oura's valuation beyond $16 billion, with the potential to raise up to $3 billion.
Underwriters and Market Implications for Oura's IPO
Goldman Sachs, Morgan Stanley, and JPMorgan are set to underwrite the offering. At a valuation of $16 billion, investors would be looking at a price of about 10 times the annualized revenue. Oura's subscription service provides AI-driven health insights based on nearly 42 billion hours of biometric data collected from users.
The S-1 filing also highlights several risks, including manufacturing cost challenges, supply chain disruptions, and legal issues regarding the accuracy of Oura's sleep-tracking claims. Originally submitted in May 2026, this confidential filing indicates that Oura has been refining its approach to the public market for several months. With such significant revenue growth and high-profile underwriters, the pricing and performance on the first day of trading are likely to influence health tech IPOs for the remainder of the year.




